anti-PD1 mAb (Fujian Haixi Pharmaceuticals)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameanti-PD1 mAb (Fujian Haixi Pharmaceuticals)
Drug Alias NamePD-1 checkpoint inhibitor (Fujian Haixi Pharmaceuticals)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionImmunostimulantsT lymphocytes stimulantsProgrammed cell death protein 1 blockers
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesFujian Haixi Pharmaceuticals Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFujian Haixi Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A